approval · primary record
ELOSULFASE ALFA
FDA · BLA · 2025-10-30
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-10-30 |
| Brand | VIMIZIM |
| Sponsor | BIOMARIN PHARM |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:39:32.056Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ELOSULFASE ALFA:2025-10-30
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Elosulfase Alfa · compound